Term ends Aug 25, 2033 · High confidence
20-year base term ends Mar 15, 2033
Held by SPR Therapeutics, Inc.
Filed Nov 6, 2023 as application 18/502,142 · Granted Mar 31, 2026
Base term plus 163 days of patent term adjustment (USPTO delay)
Today
2013
2033
Clock starts
Mar 15, 2013
Mar 15, 2013
Term ends
Aug 25, 2033
Aug 25, 2033
Granted
Mar 31, 2026
Mar 31, 2026
base term
patent term adjustment
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
163
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 11,806,533, to Aug 25, 2033. The term already ends on or before that date, so the cap shortened nothing.
0 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
9
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 163 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 1 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 15, 2013, when application 13/843,002, the earliest non-provisional in its chain, was filed (this one was filed Nov 6, 2023) | Mar 15, 2033 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +163 days, USPTO patent term adjustment record | Aug 25, 2033 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,806,533) | resolves to Aug 25, 2033, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Aug 25, 2033 | High confidence |
This family
| US 10,625,075 | In force Mar 2033 | Mar 2033 |
| US 10,632,309 | In force Mar 2033 | Mar 2033 |
| US 11,878,164 | In force Jan 2034 | Jan 2034 |
| US 11,806,533 | In force Jan 2034 | Jan 2034 |
| US 12,589,245 | this patent Aug 2033 | Aug 2033 |
| US 12,521,553 | In force Mar 2033 | Mar 2033 |
| Application 19/230,558 | Pending not computed | not computed |
| Application 19/445,724 | Pending not computed | not computed |
8 of 9 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 6, 2023 Reel 65462, frame 436 | McGee, Meredith; Boggs, Joseph W.; Chae, John; Wongsarnpigoon, Amorn; Bennett, Maria E. | SPR Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jan 30, 2024 Reel 66381, frame 75 | SPR Therapeutics, Inc. | SLR Investment Corp., as Agent | Intellectual Property Security Agreement |
| Jan 30, 2024 Reel 66412, frame 400 | SPR Therapeutics, Inc. | Gemino Healthcare Finance, LLC | Security Interest |
| Jul 15, 2026 Reel 75985, frame 374 | Gemino Healthcare Finance, LLC, D/B/A SLR Healthcare ABL | SPR Therapeutics, Inc. | Release of Security Interest |
| Jul 15, 2026 Reel 75985, frame 409 | SLR Investment Corp., as Agent | SPR Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Aug 2033
Term ends Aug 25, 2033. Maintenance fees still fall due before then
Note
The 163 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 11,806,533, ends no earlier than this term, so it caps nothing.
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.